Mocan Hognogi LD, Simiti LV. THE CARDIOVASCULAR IMPACT OF VISFATIN - AN INFLAMMATION PREDICTOR BIOMARKER IN METABOLIC SYNDROME. Med Pharm Rep [Internet]. 2016 Jul. 31 [cited 2025 Sep. 18];89(3):322-6. Available from: https://medpharmareports.com/index.php/mpr/article/view/591